Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
European Journal of Biochemistry
|
November 15, 1992
Contribution of de-novo and salvage synthesis to the uracil nucleotide pool in mouse tissues and tumors in vivo
D W Zaharevitz, L W Anderson, N M Malinowski, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
May 1, 1997
In vitro glucuronidation of D-23129, a new anticonvulsant, by human liver microsomes and liver slices
P J McNeilly, C D Torchin, L W Anderson, et al.
Pest Management Science
|
September 20, 2001
The aquatic fate of triclopyr in whole-pond treatments
D G Petty, J G Skogerboe, K D Getsinger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1997
Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation
T L Chen, M J Kennedy, L W Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1996
Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy
L W Anderson, T L Chen, O M Colvin, et al.
Journal of Pharmaceutical Sciences
|
April 1, 1995
Oxime derivatives of the intermediary oncostatic metabolites of cyclophosphamide and ifosfamide: synthesis and deuterium labeling for applications to metabolite quantification
S M Ludeman, E M Shulman-Roskes, K K Wong, et al.
Geophysical Research Letters
|
August 20, 2019
The spectroscopic foundation of radiative forcing of climate by carbon dioxide
Martin G Mlynczak, Taumi S Daniels, David P Kratz, et al.
Toxicologic Pathology
|
August 26, 1998
An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotype
J L Weaver, J F Contrera, B A Rosenzweig, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
European Journal of Biochemistry
|
November 15, 1992
Contribution of de-novo and salvage synthesis to the uracil nucleotide pool in mouse tissues and tumors in vivo
D W Zaharevitz, L W Anderson, N M Malinowski, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
May 1, 1997
In vitro glucuronidation of D-23129, a new anticonvulsant, by human liver microsomes and liver slices
P J McNeilly, C D Torchin, L W Anderson, et al.
Pest Management Science
|
September 20, 2001
The aquatic fate of triclopyr in whole-pond treatments
D G Petty, J G Skogerboe, K D Getsinger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1997
Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation
T L Chen, M J Kennedy, L W Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1996
Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy
L W Anderson, T L Chen, O M Colvin, et al.
Journal of Pharmaceutical Sciences
|
April 1, 1995
Oxime derivatives of the intermediary oncostatic metabolites of cyclophosphamide and ifosfamide: synthesis and deuterium labeling for applications to metabolite quantification
S M Ludeman, E M Shulman-Roskes, K K Wong, et al.
Geophysical Research Letters
|
August 20, 2019
The spectroscopic foundation of radiative forcing of climate by carbon dioxide
Martin G Mlynczak, Taumi S Daniels, David P Kratz, et al.
Toxicologic Pathology
|
August 26, 1998
An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotype
J L Weaver, J F Contrera, B A Rosenzweig, et al.
Page
of 6